Joint patent application with University of California, Santa Barbara further strengthens the IP position of the Company’s clean hydrogen technology SANTA CLARITA, Calif., March 12, 2026 (GLOBE ...
For both the fourth quarter and full year 2025, the increases in R&D expenses were primarily due to higher clinical trial and manufacturing costs associated with the development of soquelitinib as ...
ThreatsDay: OAuth abuse, Signal hijacks, Zombie ZIP evasion, Teams malware, AI hack, RondoDox botnet, and more cyber stories.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results